JIAN CHEN

Allopathic & Osteopathic Physicians|Internal Medicine SANTA PAULA, CA NPI 1679568612

General Payments — all program years on this page

$2,573.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 104
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $579.46 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $579.4623

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $570.8037
2019 $424.7313
2020 $123.498
2021 $166.464
2022 $505.8510
2023 $202.279
2024 $579.4623

Records — PY2024 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086218965 Bayer Healthcare Pharmaceuticals Inc. $24.57 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096566524 Novo Nordisk Inc $24.62 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096617312 Novo Nordisk Inc $16.01 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096625565 Novo Nordisk Inc $19.62 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096659401 Novo Nordisk Inc $8.71 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096754923 Novo Nordisk Inc $23.00 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096792993 Novo Nordisk Inc $28.09 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096806443 Novo Nordisk Inc $18.33 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104546920 AstraZeneca Pharmaceuticals LP $16.71 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111547812 Amgen Inc. $31.16 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111547814 Amgen Inc. $22.78 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111547816 Amgen Inc. $21.68 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111547818 Amgen Inc. $32.66 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111547820 Amgen Inc. $5.46 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111547822 Amgen Inc. $28.82 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114613574 Exact Sciences Corporation $14.84 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117222667 Amgen Inc. $25.49 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118106853 Boehringer Ingelheim Pharmaceuticals, Inc. $19.33 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125188344 Abbott Laboratories $23.31 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135048690 Lilly USA, LLC $23.16 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145840599 Mannkind Corporation $113.07 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147898120 Supernus Pharmaceuticals, Inc. $24.68 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148020574 Bausch Health US, LLC $13.36 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.